Margie McGlynn

Track

Insider profile

Currently holds positions in Air Products and Chemicals, Inc., Amicus Therapeutics, Inc. and Vertex Pharmaceuticals Incorporated

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Air Products and Chemicals, Inc. March 17, 2005 -
Independent Director Amicus Therapeutics, Inc. Oct. 1, 2009 -
Independent Director Vertex Pharmaceuticals Incorporated May 1, 2011 -
Margie McGlynn's trades of Amicus Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
65.95
Quantity 15,566 +6.4%
Value US$1,284,958
Transaction date
Proposed sale
Price
450.80
Quantity 12,274
Value US$364,860
Transaction date
Sale
Price
48.95
Quantity 47,388 +42.3%
Value US$1,463,136
Transaction date
Proposed sale
Price
13.29
Quantity 7,500
Value US$99,675
Transaction date
Purchase
Price
48.00
Quantity 2,500 +55.6%
Value US$120,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-06 2024-03-05
S Sale
15,566 +6.4%
65.95
US$1,284,958 		15,566 +6.4% 65.95 US$1,284,958
2024-03-05 2024-03-05
PrS Proposed sale
12,274
450.80
US$364,860 		12,274 450.80 US$364,860
2024-03-06 2024-03-04
S Sale
47,388 +42.3%
48.95
US$1,463,136 		47,388 +42.3% 48.95 US$1,463,136
2024-03-04 2024-03-04
PrS Proposed sale
7,500
13.29
US$99,675 		7,500 13.29 US$99,675
2023-01-17 2023-01-13
PlS Planned sale
15,000 -22.8%
13.03
US$195,387 		15,000 -22.8% 13.03 US$195,387
2022-05-04 2022-05-02
PlS Planned sale
15,000 -28.3%
6.99
US$104,896 		15,000 -28.3% 6.99 US$104,896
2022-04-12 2022-04-08
PlS Planned sale
100 -8.3%
281.49
US$28,149 		100 -8.3% 281.49 US$28,149
2022-04-12 2022-04-08
PlS Planned sale
4,900 -80.3%
280.19
US$1,372,931 		4,900 -80.3% 280.19 US$1,372,931
2022-04-04 2022-03-31
PlS Planned sale
1,011 -47.9%
262.97
US$265,863 		1,011 -47.9% 262.97 US$265,863
2022-04-04 2022-03-31
PlS Planned sale
2,970 -58.5%
262.37
US$779,239 		2,970 -58.5% 262.37 US$779,239
2022-04-04 2022-03-31
PlS Planned sale
1,019 -16.7%
261.28
US$266,244 		1,019 -16.7% 261.28 US$266,244
2022-02-01 2022-01-28
PlS Planned sale
212 -16.2%
243.24
US$51,567 		212 -16.2% 243.24 US$51,567
2022-02-01 2022-01-28
PlS Planned sale
2,087 -61.4%
242.78
US$506,682 		2,087 -61.4% 242.78 US$506,682
2022-02-01 2022-01-28
PlS Planned sale
800 -19.1%
241.83
US$193,464 		800 -19.1% 241.83 US$193,464
2022-02-01 2022-01-28
PlS Planned sale
1,901 -31.2%
240.53
US$457,248 		1,901 -31.2% 240.53 US$457,248
2020-04-20 2020-04-17
PlS Planned sale
10,000 -31.2%
11.00
US$110,000 		10,000 -31.2% 11.00 US$110,000
2020-01-10 2020-01-09
PlS Planned sale
20,000 -47.5%
10.00
US$200,000 		20,000 -47.5% 10.00 US$200,000
2019-10-24 2019-10-22
PlS Planned sale
20,000 -82.9%
190.00
US$3,800,000 		20,000 -82.9% 190.00 US$3,800,000
2004-02-04 2004-02-03
B Purchase
2,500 +55.6%
48.00
US$120,000 		2,500 +55.6% 48.00 US$120,000